Drug company job cuts surged last year, and this year is starting with more
The job cuts reflect the normal maturation of companies such as Alameda-based Scribe, which is moving from a preclinical to ...
Endocrinology Advisor16d
Serum CXCL13 Levels Show Potential as a Biomarker for Tailoring Early RA Treatment
High serum CXCL13 levels are predictive of treatment failure with first-line MTX among patients with early RA.